Search details
1.
Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology study.
Brain
; 146(3): 1166-1174, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-35511164
2.
Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions.
Alzheimers Dement
; 20(1): 728-740, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37917365
3.
Primary retinal tauopathy: A tauopathy with a distinct molecular pattern.
Alzheimers Dement
; 20(1): 330-340, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37615275
4.
Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.
Acta Neuropathol
; 145(2): 197-218, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36480077
5.
Tear biomarkers for Alzheimer's disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study.
BMC Neurol
; 23(1): 293, 2023 Aug 05.
Article
in English
| MEDLINE | ID: mdl-37543602
6.
Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
Brain
; 145(8): 2869-2881, 2022 08 27.
Article
in English
| MEDLINE | ID: mdl-35259207
7.
A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic setting.
Alzheimers Dement
; 19(5): 2006-2013, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36419238
8.
Quantification of [18 F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project.
Alzheimers Dement
; 19(6): 2397-2407, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36478646
9.
Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial.
Alzheimers Dement
; 19(1): 285-295, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35366050
10.
[A survey study towards the opinions of clinicians, patients and care partners regarding computer tools in the memory clinic: sense or nonsense?] / Een vragenlijstonderzoek naar de mening van clinici, patiënten en naasten over computertools in de geheugenpolikliniek: zin of onzin?.
Tijdschr Gerontol Geriatr
; 54(1)2023 Jan 25.
Article
in Dutch
| MEDLINE | ID: mdl-37022048
11.
The severity of behavioural symptoms in FTD is linked to the loss of GABRQ-expressing VENs and pyramidal neurons.
Neuropathol Appl Neurobiol
; 48(4): e12798, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35152451
12.
Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.
Eur Radiol
; 32(11): 7789-7799, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35639148
13.
The Impact of Amyloid PET Disclosure on Quality of Life in Patients With Young Onset Dementia.
Alzheimer Dis Assoc Disord
; 36(1): 1-6, 2022.
Article
in English
| MEDLINE | ID: mdl-35200198
14.
Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease.
J Neurol Neurosurg Psychiatry
; 2021 Apr 13.
Article
in English
| MEDLINE | ID: mdl-33850001
15.
Retinal imaging in Alzheimer's and neurodegenerative diseases.
Alzheimers Dement
; 17(1): 103-111, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33090722
16.
The coarse-grained plaque: a divergent Aß plaque-type in early-onset Alzheimer's disease.
Acta Neuropathol
; 140(6): 811-830, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32926214
17.
Communicating uncertainties when disclosing diagnostic test results for (Alzheimer's) dementia in the memory clinic: The ABIDE project.
Health Expect
; 23(1): 52-62, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31638322
18.
Development of memory clinics in the Netherlands over the last 20 years.
Int J Geriatr Psychiatry
; 34(8): 1267-1274, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31034652
19.
Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project.
Alzheimers Dement
; 15(11): 1458-1467, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31594684
20.
Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
J Neuroinflammation
; 15(1): 170, 2018 May 29.
Article
in English
| MEDLINE | ID: mdl-29843759